Charles Berman is a principal shareholder with the law firm Greenberg Traurig, LLP, in Santa Monica, California, and he is Co-Chair of the national patent
Berman currently serves as Chair of Fellows of the American Intellectual Property Law Association (AIPLA), where he was a founding fellow, and has also
He is a frequently invited speaker, has written
Jeff Lawrence is President & CEO of Clivia Systems (www.cliviasystems.com), former CTO of Intel's Network Communications Group, and co-founder and former President and CEO of Trillium Digital Systems. Trillium was a leading provider of communications software solutions to communications equipment manufacturers building the
Lawrence is also Trustee of The Lawrence Foundation (www.thelawrencefoundation.org), a family foundation focused on grant making to environmental, education, health, and human services causes. He has a B.S.E.E. from UCLA, was co-recipient of the Greater Los Angeles Entrepreneur of the Year award, and recipient of the UCLA School of Engineering's Professional Achievement award. Jeff also
Larry Bock is the Founder and Executive Chairman of Nanosys Inc. He is a General Partner of CW Ventures, a life sciences venture capital fund, and a Special Advisor to Lux Capital, a nanotechnology-focused venture capital fund. He is a member of the board of directors of FEI Corporation, the leading supplier of tools for nanotechnology research.
Bock was the Founder and initial CEO of Neurocrine Biosciences, Pharmacopeia, GenPharm International, Caliper Technologies, Illumina Technologies, IDUN Pharmaceuticals, Metra Biosystems, and FASTTRACK Systems. Bock was a co-founder of Argonaut Technologies, ARIAD Pharmaceuticals, Athena Neurosciences, Vertex Pharmaceuticals, and Onyx Pharmaceuticals. He also helped found and is on the scientific advisory board of Conforma Therapeutics.
Bock started his career as a Researcher at Genentech, Inc., in the field of infectious diseases, where he was on the team that received the AAAS Newcomb Cleveland Prize for demonstrating the first recombinant DNA vaccine.
He has received several awards and honors. He was selected by Venture Capital Journal as one of the "Ten Most Influential Venture Capitalists," by Red Herring as one of the "Top Ten Innovators," by Forbes-Wolfe NanoReport as the "Number One Powerbroker in Nanotechnology," by Ernst & Young as a finalist for "Entrepreneur of the Year," and by Small Times as "Innovator of the Year" and one of "Top 3 Business Leaders of the Year." He received the Einstein Award from the Jerusalem Foundation for lifetime contributions in the field of life sciences.
Bock and his wife, Diane, founded Community Cousins, a